ConductScience.org, home

Paper39166347

Methods for causality assessment of idiosyncratic drug-induced liver injury.

García-Cortés M and 2 others. Liver Int, 2025. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Methods for causality assessment of idiosyncratic drug-induced liver injury. Papers, record 39166347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39166347

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methods for causality assessment of idiosyncratic drug-induced liver injury.
PubMed
Journal
Liver Int
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
3.64, provisional
iCite
Revised in PubMed
2026-07-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1García-Cortés MMirenhttps://orcid.org/0000-0003-0410-8273
2Matilla-Cabello GGonzalohttps://orcid.org/0000-0001-8295-6708
3Lucena MIM Isabelhttps://orcid.org/0000-0001-9586-4896

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chemical and Drug Induced Liver InjuryMajor topic
Humans
Biomarkers

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PI21/01248Instituto de Salud Carlos IIIPubMed
PT23/00137Instituto de Salud Carlos IIIPubMed
PID2022-140169OB-C21Agencia Estatal de InvestigaciónPubMed
FPU22/03868Ministerio de Ciencia, Innovación y UniversidadesPubMed

Source PubMed

Download CSV of grants

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136496055Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.Gastroenterology2023https://conductscience.org/library/papers/36496055PubMed
238131512Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.Liver Int2024https://conductscience.org/library/papers/38131512PubMed
319132805Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.Drug Saf2009https://conductscience.org/library/papers/19132805PubMed
420949552Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.Hepatology2010https://conductscience.org/library/papers/20949552PubMed
516083708Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.Gastroenterology2005https://conductscience.org/library/papers/16083708PubMed
635899490A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.Liver Int2023https://conductscience.org/library/papers/35899490PubMed
738402364Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update.Hepatol Int2024https://conductscience.org/library/papers/38402364PubMed
831168513The Contents of Herbal and Dietary Supplements Implicated in Liver Injury in the United States Are Frequently Mislabeled.Hepatol Commun2019https://conductscience.org/library/papers/31168513PubMed
936869085Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans.Nat Commun2023https://conductscience.org/library/papers/36869085PubMed
1037164270Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.J Hepatol2023https://conductscience.org/library/papers/37164270PubMed
1118284654Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.Aliment Pharmacol Ther2008https://conductscience.org/library/papers/18284654PubMed
1214585395Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting.Hepatol Res2003https://conductscience.org/library/papers/14585395PubMed
1338992407Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network.Clin Gastroenterol Hepatol2025https://conductscience.org/library/papers/38992407PubMed
1421349301Causality assessment methods in drug induced liver injury: strengths and weaknesses.J Hepatol2011https://conductscience.org/library/papers/21349301PubMed
1515588780Validity study of a new diagnostic scale for drug-induced liver injury in Japan-comparison with two previous scales.Hepatol Res2004https://conductscience.org/library/papers/15588780PubMed
1636174069A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT).PLoS One2022https://conductscience.org/library/papers/36174069PubMed
1733609753Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver.Ann Hepatol2021https://conductscience.org/library/papers/33609753PubMed
1826459430Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum.Front Med2015https://conductscience.org/library/papers/26459430PubMed
199303497Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.Hepatology1997https://conductscience.org/library/papers/9303497PubMed
2031439850Drug-induced liver injury.Nat Rev Dis Primers2019https://conductscience.org/library/papers/31439850PubMed

See all 64 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42326456Ileal Bile Acid Transporter Inhibitors for Symptomatic Cholestasis due to Vanishing Bile Duct Syndrome in Adults.ACG Case Rep J2026https://conductscience.org/library/papers/42326456PubMed
42244311[Differences in the mechanisms, diagnostic biomarkers, and therapeutic strategies of drug-induced liver injury caused by traditional Chinese and Western medicines].Zhong Nan Da Xue Xue Bao Yi Xue Ban2026https://conductscience.org/library/papers/42244311PubMed
41970063
Anti-tubercular Drugs Dominate Drug-Induced Liver Injury in Northern India: An Observational, Cross-Sectional Study of 100 Cases Using the Revised Electronic Causality Assessment Method (RECAM) and Drug-Induced Liver Injury Network (DILIN) Criteria.
Cureus2026https://conductscience.org/library/papers/41970063PubMed
41910704A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.Drug Saf2026https://conductscience.org/library/papers/41910704PubMed
41630224Diagnostic value of drug withdrawal observation in drug-induced liver injury: A retrospective study.Medicine (Baltimore)2026https://conductscience.org/library/papers/41630224PubMed
40501468Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury.World J Hepatol2025https://conductscience.org/library/papers/40501468PubMed
40225434Acetazolamide-Induced Liver Injury: A Case Report and Literature Review.Cureus2025https://conductscience.org/library/papers/40225434PubMed
39796705Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives.Cancers (Basel)2024https://conductscience.org/library/papers/39796705PubMed
39166347Methods for causality assessment of idiosyncratic drug-induced liver injury.Liver Int2025https://conductscience.org/library/papers/39166347PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39166347

GET https://conductscience.org/api/papers/v1/39166347/references?page=2